[ACEA BIOSCIENCES | Immunotherapy Research Grant]
Event details
| Date | 15.09.2018 |
| Category | Call for proposal |
Aim: As an extension of their support for our 6th annual Cancer Immunotherapy Month this past June, ACEA Biosciences is providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. The research grant winner will be provided access to an xCELLigence® Real Time Cell Analysis (RTCA) SP instrument, consumables to run 96 well experiments, and consultation for up to 6 months.
The xCELLigence RTCA instruments dynamically monitor the efficacy of target tumor cell killing by novel therapeutic drugs or other treatments that utilize the body’s own immune system to combat cancer. This technology enables scientists to quantitatively measure the cytotoxic activity of antibodies, genetically engineered CAR-T cells, immune checkpoint inhibitors, and much more.
Duration: 6 months
Award: Use of Instrument
Consumables (up to USD $1000)
Consultation
Eligibility: Each Applicant must be an individual who is at least 18 years old. Applications that propose research on IVD-regulated products (for In Vitro Diagnostic Use), use in clinical trials, or any use in humans are excluded from the xCELLigence Research Grant program and will not be accepted.
How to Apply: An online form must be completed, which can be accessed here.
Application Deadline: 15 September 2018
Further information
The xCELLigence RTCA instruments dynamically monitor the efficacy of target tumor cell killing by novel therapeutic drugs or other treatments that utilize the body’s own immune system to combat cancer. This technology enables scientists to quantitatively measure the cytotoxic activity of antibodies, genetically engineered CAR-T cells, immune checkpoint inhibitors, and much more.
Duration: 6 months
Award: Use of Instrument
Consumables (up to USD $1000)
Consultation
Eligibility: Each Applicant must be an individual who is at least 18 years old. Applications that propose research on IVD-regulated products (for In Vitro Diagnostic Use), use in clinical trials, or any use in humans are excluded from the xCELLigence Research Grant program and will not be accepted.
How to Apply: An online form must be completed, which can be accessed here.
Application Deadline: 15 September 2018
Further information
- More information about the program is available here.
- The application portal can be found here.
- For any other questions, please contact the Research Office.
Practical information
- General public
- Free